CRELUX, part of WuXi AppTec’s Research Service Division, is a global provider of structure based drug discovery solutions. We have been delivering customized and integrated services in drug discovery, X-ray crystallography, protein supply, biophysical analysis and fragment screening, to support small and large molecule, as well as biopharmaceutical drug discovery, for more than a decade. Our mission is to enable our clients to perform their work faster, more efficiently and more successfully. Integrating the comprehensive portfolio of services offered by our parent company WuXi AppTec, CRELUX offers a unique opportunity for our collaborators to accelerate discovery activities.


Imprint:
CRELUX GmbH
Am KIopferspitz 19a
82152 Martinsried
Germany
www.crelux.com
crelux_info@wuxiapptec.com
phone: +49 89 7007600
VAT: DE242220245
Amtsgericht München HRB 165552
Managing Director: Dr. Gundel Hager

Biotechnology

Life Sciences

Research

CRELUX, a WuXi AppTec Company

Michael Schaeffer

Mahesh Lingaraju

Thomas Waldmann

The Science Team at CRELUX, a WuXi AppTec Company, is primarily responsible for advancing structure-based drug discovery projects through cutting-edge techniques such as X-ray crystallography, protein supply, biophysical analysis, and fragment screening. The team, composed of senior scientists and specialists in medicinal chemistry, collaborates closely to develop customized solutions that accelerate the identification and optimization of both small and large molecule therapeutics. Their expertise supports clients in achieving more efficient and successful drug discovery outcomes.

Science Team

About

Team members